Objectives
The primary objective of the meta-trial is to demonstrate that inhaled
nebulised UFH in hospitalised patients with COVID-19 who do not require
immediate invasive mechanical ventilation, significantly reduces the
proportion of patients who are intubated to receive invasive mechanical
ventilation at day 28, compared to standard care alone.